Physician profile
Christopher Locke
NPI 1609837723
$5,507.46
in general payments reported to CMS, 2019-2025
11 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,769 · 2020: $868 · 2021: $70.01 · 2022: $125 · 2023: $143 · 2024: $146 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $4,736.16 | 2019-2025 | Puraply Wound Matrix, Puraply |
| Smith+Nephew, INC. | $186.29 | 2020-2025 | Grafix Pl, Stravix |
| Wright Medical Technology, INC. | $119.31 | 2019-2020 | |
| Boston Scientific Corporation | $110.73 | 2024 | |
| Orthofix Medical, INC. | $105.68 | 2020-2025 | Physio-Stim |
| Tactile Systems Technology INC | $76.28 | 2020-2025 | Nimbl, Flexitouch Plus |
| Vertex Pharmaceuticals Incorporated | $56.08 | 2025 | |
| Polynovo North America LLC | $37.81 | 2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $35.51 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $22.87 | 2025 | Citrefix |
| Bioventus LLC | $20.74 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Locke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.